FDA-Inspected Site

Akorn, Inc.

22 FDA inspections are on record for Akorn, Inc. in Decatur, United States.

483· Form 483 issued

Decatur, United States · Last updated August 15, 2026

Overview

  • 22 FDA inspections are on record.
  • 11 inspections produced a Form 483.
  • The most recent recorded inspection date is 2022-04-08.

At a glance

Inspections

22

Form 483s

11

EIRs

5

Last outcome

Form 483

Inspection history

FDA inspections on record, most recent first.

InspectionCategoryOutcomeForm 483
28 Mar 2022 – 8 Apr 2022Human Drugs483View 483 →
9 Apr 2018 – 16 May 2018Human DrugsWLOn file
20 Apr 2017 – 26 Apr 2017Human Drugs483View 483 →
5 Dec 2016 – 9 Dec 2016Human DrugsClean
1 Jun 2016 – 10 Jun 2016Human Drugs483View 483 →
28 May 2014 – 6 Jun 2014Medical Devices & Rad Health483View 483 →
15 Apr 2013 – 3 May 2013Human Drugs483View 483 →
26 Oct 2012Not recorded483View 483 →
25 May 2012Not recorded483View 483 →
5 Aug 2011Not recordedClean
17 Sep 2010Not recorded483View 483 →
30 Jun 2009Not recorded483View 483 →

Observations on record

Form 483 observations cited at this site, most recent first.

8 Apr 2022
21 CFR 211.100(a)

Absence of Written Procedures

Cited by Ross J Grigsby, Michele L Glendenning, Jacob G Lutz, Eboni S Funderburk

8 Apr 2022
21 CFR 211.113(b)

Procedures for sterile drug products

Cited by Ross J Grigsby, Michele L Glendenning, Jacob G Lutz, Eboni S Funderburk

8 Apr 2022
21 CFR 211.192

Investigations of discrepancies, failures

Cited by Ross J Grigsby, Michele L Glendenning, Jacob G Lutz, Eboni S Funderburk

26 Apr 2017
21 CFR 211.113(b)

Validation lacking for sterile drug products

Cited by Brian D Nicholson

26 Apr 2017
21 CFR 211.113(b)

Validation lacking for sterile drug products

Cited by Brian D Nicholson

Investigators

FDA investigators tied to this site in the record.

Eboni S Funderburk1 insp.
Denise M Digiulio1 insp.
Bruce H Mccullough1 insp.
Phung T Nguyen1 insp.

Recurring citations

CFR citation patterns observed across this site's inspections.

CitationWhat it coversCited
21 CFR 211.192Cited across public-safe Form 483 observations11x
21 CFR 211.22(d)Cited across public-safe Form 483 observations10x
21 CFR 211.100(b)Cited across public-safe Form 483 observations6x
21 CFR 211.110(a)Cited across public-safe Form 483 observations6x
21 CFR 211.160(b)Cited across public-safe Form 483 observations6x
21 CFR 211.113(b)Cited across public-safe Form 483 observations5x
21 CFR 211.194(a)(2)Cited across public-safe Form 483 observations5x
21 CFR 211.100(a)Cited across public-safe Form 483 observations3x
21 CFR 211.63Cited across public-safe Form 483 observations3x
21 CFR 211.188Cited across public-safe Form 483 observations2x
21 CFR 211.67(a)Cited across public-safe Form 483 observations2x
21 CFR 211.84(d)(2)Cited across public-safe Form 483 observations2x
21 CFR 211.84(e)Cited across public-safe Form 483 observations2x
21 CFR 211.115(a)Cited across public-safe Form 483 observations1x
21 CFR 211.137(a)Cited across public-safe Form 483 observations1x
21 CFR 211.160(a)Cited across public-safe Form 483 observations1x
21 CFR 211.165(f)Cited across public-safe Form 483 observations1x
21 CFR 211.180(e)Cited across public-safe Form 483 observations1x
21 CFR 211.180(e)(2)Cited across public-safe Form 483 observations1x
21 CFR 211.186(b)(9)Cited across public-safe Form 483 observations1x
21 CFR 211.188(b)(12)Cited across public-safe Form 483 observations1x
21 CFR 211.198(a)Cited across public-safe Form 483 observations1x
21 CFR 211.25(a)Cited across public-safe Form 483 observations1x
21 CFR 211.56(a)Cited across public-safe Form 483 observations1x
21 CFR 211.67(b)(3)Cited across public-safe Form 483 observations1x
21 CFR 211.68(a)Cited across public-safe Form 483 observations1x
21 CFR 211.80(a)Cited across public-safe Form 483 observations1x
21 CFR 211.84(a)Cited across public-safe Form 483 observations1x

Full site report

Get the verbatim findings behind Akorn, Inc.'s 11 Form 483s

Source PDFs, verbatim observations, and recurring CFR citations, so your team knows what this site gets cited for.

  • The site's full inspection history, with every Form 483 and its outcome
  • Warning letters and recalls tied to the company behind it
  • Whether recurring CFR citations get closed out or repeat